Follow the 동성제약 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 동성제약 has published 41 insider filings. Market capitalisation: €171.5bn. The latest transaction was reported on 6 April 2026 (Purchase). Among the most active insiders: 이양구. Every trade is free.
41
Insider Decl.
n/a
Thresholds
€40m
29 ops.
Buy Volume
n/a
2 ops.
Sell Volume
19Σ signal
Buys €40mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,334 of 29,063 companies
24.8
score / 100
Value
15
Quality
34
FCF yld-8.3%
Earn yld-15%
EV/EBITDA·
ROE2.9%
Gross mgn43%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
동성제약 es una empresa que opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. Se enfoca en la investigación, desarrollo y fabricación de productos farmacéuticos.